![](https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)
Recommendations for Investigational and Licensed COVID-19 Convalescent Plasma; Guidance for Industry
Docket Number: FDA-2024-D-2442 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research This guidance provides FDA’s recommendations to blood establishments for the submission of a Biologics License Application (BLA) for the …